참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Flufenamic Acid | HCID 3371 | — |
| 반응물 | Thiosemicarbazide | HCID 2723789 | — |
| 용매 | Pyridine | HCID 1049 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | HCID 15678604 | HCID 15678604 | 44% |
반응 단계
N,N'-Carbonyldiimidazole (4.56 g, 27.6 mmol) is added to a room temperature solution of flufenamic acid (5.07 g, 18.0 mmol) in 70 ml of tetrahydrofuran. The clear yellow solution is stirred at room temperature for three hours. The solution is then added via cannula to a suspension of thiosemicarbazide (3.41 g, 37.5 mmol) in 55 ml of pyridine. The suspension is heated at reflux overnight. The clear orange solution is concentrated in vacuo and the residue is partitioned between ethyl acetate and water. The organic layer is washed with water, dried over magnesium sulfate and concentrated. The resulting solid is slurried with a 1:3 mixture of ethyl acetate and hexane. The off-white solid is collected by filtration providing 2.80 g (44%) of 2-[(3-trifluoromethylphenyl)amino]-benzoic acid, 2-(aminothioxomethyl)hydrazide.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05066668 |
|---|
| 출처 데이터셋 | uspto-grants-1991_11 |
|---|
| ORD ID | ord-fbdefd5d3db34fa6a34cfed71c317fae |
|---|
| 출처 메모 | uspto-grants-1991_11 |
|---|